Inventor · disambiguated record
Guodong Chang
Also filed as: CHANG GUODONG
8 granted patents·13 pending applications·1 citations·filing 2007–2023
74Inventor score
Top patents by PatentIndex Score
21 records- 0172US2024165140A1Medication for inhibiting dna-pkcsUNIV TSINGHUA·Filed 2023·Application pending·0 cites
- 0265US10647968B2Endostatin mutants with mutations at ATP binding sitesLUO YONGZHANG·Filed 2012·Granted May 12, 2020·1 cites·6 claims
- 0360US8975030B2Method for cancer detectionUNIV TSINGHUA·Filed 2013·Granted Mar 10, 2015·0 cites·12 claims
- 0458US10054590B2Use of nucleolin as a biomarker for lymphangiogenesis in a cancer prognosis and therapyUNIV TSINGHUA·Filed 2013·Granted Aug 21, 2018·0 cites·18 claims
- 0558US9815906B2Method of inhibiting or treating cancer metastasisUNIV TSINGHUA·Filed 2015·Granted Nov 14, 2017·0 cites·5 claims
- 0657US2020237796A1Medication for inhibiting dna-pkcsUNIV TSINGHUA·Filed 2018·Application pending·0 cites
- 0756US2010184661A1Conjugate comprising angiostation or its fragment, the method for producing the conjugate and use thereofPROTGEN LTD·Filed 2008·Application pending·0 cites
- 0853US8389684B2Tumor biomarkerLUO YONGZHANG·Filed 2010·Granted Mar 5, 2013·0 cites·3 claims
- 0950US2010285103A1Medicament for treatment of tumors and the use thereofLUO YONGZHANG·Filed 2007·Application pending·0 cites
- 1049US2014056966A1Conjugate angiostation or its fragment, the method of producing the conjugate and use thereofLUO YONGZHANG·Filed 2012·Application pending·0 cites
- 1148US2023265166A1Young and undamaged human serum albumin improves longevity of humanSHENZHEN PROTGEN LTD·Filed 2021·Application pending·0 cites
- 1248US2013023479A1Use of nucleolin as a biomarker for lymphangiogenesis in cancer prognosis and therapyPROTGEN LTD·Filed 2012·Application pending·0 cites
- 1347US11098104B2Pegylated endostatin analogue and application thereofBEIJING PROTGEN LTD·Filed 2017·Granted Aug 24, 2021·0 cites·19 claims
- 1447US2018360922A1Medicament for treatment of tumors and the use thereofUNIV TSINGHUA·Filed 2018·Application pending·0 cites
- 1546US9364493B2Methods and compositions for enhancing the uptake of therapeutic agents by target cellsLUO YONGZHANG·Filed 2012·Granted Jun 14, 2016·0 cites·14 claims
- 1646US2016178633A1Tumor biomarkerUNIV TSINGHUA·Filed 2014·Application pending·0 cites
- 1745US2018094051A1Method for inhibiting lymphangiogenesis by administration of an inhibitor of the cxcl12 pathwayUNIV TSINGHUA·Filed 2017·Application pending·0 cites
- 1844US12454566B2Construction of engineering bacteria for high expression of recombinant human serum albuminSHENZHEN PROTGEN LTD·Filed 2017·Granted Oct 28, 2025·0 cites·12 claims
- 1944US2023390364A1Use of human serum albumin in treatment of diseasesSHENZHEN PROTGEN LTD·Filed 2021·Application pending·0 cites
- 2043US2010303893A1Novel compound for treatment of tumorLUO YONGZHANG·Filed 2007·Application pending·0 cites
- 2134US2014193424A1Method and medicament for inhibiting lymphangiogenesisBEIJING PROTGEN LTD·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Guodong Chang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →